Showing results (2901-2910 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 16, 2016
Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatmentDan Ishihara, Laurentiu Pop, Tsuguhide Takeshima, et al.
Cancer Immunology, Immunotherapy : CII|October 8, 2016
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulationPeter Ellmark, Sara M Mangsbo, Christina Furebring, et al.
Cancer Immunology, Immunotherapy : CII|October 8, 2016
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinomaAjjai Alva, Gregory A Daniels, Michael K K Wong, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2014
Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animalsVolker Schirrmacher
Cancer Immunology, Immunotherapy : CII|March 11, 2014
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanomaSander Kelderman, Bianca Heemskerk, Harm van Tinteren, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2008
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cellsPatrizia Stoitzner, Laura K Green, Jae Y Jung, et al.
Cancer Immunology, Immunotherapy : CII|March 18, 2008
Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?Karin E de Visser
Cancer Immunology, Immunotherapy : CII|March 18, 2008
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanomaOliver G Goldstein, Laela M Hajiaghamohseni, Shereen Amria, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2008
Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsMinu K Srivastava, Jacobus J Bosch, James A Thompson, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2008
Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responsesJian-Qing Gao, Naoko Kanagawa, Dong-Hang Xu, et al.
Pageof 652